NarbadLab (@narbadlab.bsky.social)

Genome sequence of Eubacterium callanderi AM6, isolated from a Parkinson’s disease patient | Microbiology Resource Announcements Eubacterium callanderi is a non-motile, gram-positive, anaerobic gut bacterium that produces short-chain fatty acids, supporting gut health and potentially benefiting conditions like Inflammatory Bowel Disease (IBD) and metabolic syndromes (1–3). Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by motor dysfunction, dopamine loss, and potential gut-brain axis involvement. Studying Eubacterium callanderi from PD patients may reveal its role in gut-brain interactions, neuroinflammation, and potential as a biomarker or therapeutic target. There is limited research on Eubacterium callanderi isolated from patients with PD. Here, we report the genome sequence of Eubacterium callanderi strain AM6, isolated from the fecal sample of a PD patient. https://journals.asm.org/doi/10.1128/mra.00039-25